BASES FISIOPATOLÓGICAS Y TERAPEÚTICAS EN ENFERMEDADES AUTOINMUNES
BAFITEA
![Foto de BASES FISIOPATOLÓGICAS Y TERAPEÚTICAS EN ENFERMEDADES AUTOINMUNES](/img/grupo.png)
![Foto de Complexo Hospitalario Universitario de Vigo](/img/noimage_org.png)
Complexo Hospitalario Universitario de Vigo
Vigo, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (41)
2024
2023
-
External clinical validation of automated software to identify structural abnormalities and microhaemorrhages in nailfold videocapillaroscopy images
Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1605-1611
-
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Scientific reports, Vol. 12, Núm. 1, pp. 5289
-
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
Autoimmunity Reviews, Vol. 21, Núm. 10
-
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Therapeutic Advances in Musculoskeletal Disease, Vol. 14
2021
-
Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))
Autoimmunity Reviews
-
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)
Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Longterm efficacy and safety of monotherapy versus combination therapy in systemic sclerosis-associated pulmonary arterial hypertension: A retrospective RESCLE registry study
Journal of Rheumatology, Vol. 47, Núm. 1, pp. 89-98
-
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Autoimmunity Reviews, Vol. 19, Núm. 5
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry
Clinical Rheumatology, Vol. 38, Núm. 4, pp. 1117-1124
-
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135
2018
-
Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study (Clinical Rheumatology, (2018), 37, 4, (999-1009), 10.1007/s10067-017-3936-7)
Clinical Rheumatology
-
First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study
Clinical Rheumatology, Vol. 37, Núm. 4, pp. 999-1009
-
Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry
Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 6, pp. 849-857
-
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group
Rheumatology International, Vol. 38, Núm. 3, pp. 363-374